Choice of cancer vaccine is branded a missed opportunity by charities

Kmietowicz, Zosia
June 2008
BMJ: British Medical Journal (International Edition);6/28/2008, Vol. 336 Issue 7659, p1456
Academic Journal
The article discusses how health charities are criticizing the adoption of the drug Cervarix into national immunisation initiatives in Great Britain. Cervarix, developed by the pharmaceutical firm GlaxoSmithKline is designed to vaccinate women against human papillomaviruses, which can cause cervical cancer. Charities have suggested that the drug Gardasil has the ability to protect women from a greater variety of human papillomaviruses.


Related Articles

  • HPV vaccine strategies: the cost of HPV and the choice of vaccine. Morris, Sheldon R. // Sexually Transmitted Infections;Sep2009, Vol. 85 Issue 5, p315 

    The author reflects on the strategies for selecting the right human papillomavirus (HPV) vaccines for the prevention of cervical cancer. He cites efficacious vaccines that are approved in many developed countries which include Merck quadrivalent HPV 6/11/16/18 (Gardisil) and GSK bivalent HPV...

  • Response to The HPV Vaccination Campaign: A Project of Moral Regulation in an Era of Biopolitics. MACDONALD, LIANE; DEEKS, SHELLEY; DOYLE, CAROLYN // Canadian Journal of Sociology;Fall2010, Vol. 35 Issue 4, p627 

    In this article the authors discuss the Canadian public health campaign regarding the human papillomavirus (HPV) vaccination used for the prevention of cervical cancer. They argue that a voluntary program in schools could provide access to the HPV vaccination for low-income and Aboriginal women,...

  • HPV vaccine and anal cancer risk.  // Travel Medicine Advisor;Dec2011 Supplement, p1 

    The article reports on the recommendation of the Advisory Committee on Immunization Practices of the Centers for Disease Prevention and Control (CDC) to administer human papillomavirus (HPV) vaccines to 11- and 12-year-old boys in the U.S. It is inferred that the HPV vaccine reduces the risk of...

  • Prevención primaria del cáncer cervicouterino. Vargas-Hernández, Víctor Manuel; Acosta-Altamirano, Gustavo // Cirugia y Cirujanos;May/Jun2012, Vol. 80 Issue 3, p291 

    Cervical cancer is a global public health problem related to infection by human papilloma virus. Countries with organized programs for detection and treatment of precancerous lesions and cervical cancer prevent 80% of cases; however, prevention-based cytology, colposcopy and treatment of...

  • "Baby Doc" Eden Explains. Eden, Alvin N. // Pediatrics for Parents;Nov/Dec2010, Vol. 26 Issue 11/12, p28 

    The article offers information on the vaccines available for the prevention of human papillomavirus (HPV) infections in adolescents. According to the author, HPV, which is often associated with cervical cancer, can now be prevented by licensed vaccines such as Gardasil and Cervarix. It notes...

  • Bivalent HPV vaccine recommended. Blazek, Nicole; Zacharyczuk, Colleen // Infectious Disease News;Nov2009, Vol. 22 Issue 11, p35 

    The article reports that the U.S. Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices has recommended the use of bivalent human papillomavirus vaccine in the prevention of cervical cancer in girls and women ages 10-25 years.

  • Update on Vaccination Against Human Papillomavirus (HPV). Weber, Carol J. // Urologic Nursing;Aug2007, Vol. 27 Issue 4, p320 

    The article presents information on the U.S. Advisory Committee on Immunization Practices' (ACIP) guidelines for compulsory vaccination of girls and young women against the human papillomavirus (HPV). Many U.S. states have responded positively by making vaccination a condition of enrollment for...

  • Cervical cancer and the HPV vaccination. Hughes, Cathryn // Primary Health Care;Jun2008, Vol. 18 Issue 5, p25 

    The article focuses on cervical cancer and the human papillomavirus (HPV) immunization program. The HPV has been considered as a major cause of cervical cancer. Screening is a public health intervention used on women to detect and treat early abnormalities to prevent the development of cervical...

  • VACCINATION AGAINST THE HPV POSSIBLE PRIMARY PREVENTION FOR NEOPLASIA. Ioan, Raluca Gabriela; Dincă, Gabriela Adriana; Ionescu, Mioara // Romanian Journal of Pediatrics;2013, Vol. 62 Issue 4, p355 

    The frequency of different types of cancer (among which the cervical cancer covers 55%) etiologically correlated with the Human Papillomavirus (HPV) infection is worrying particularly amongst early ages. Demonstrating the presence and the oncogene role of some HPV types opened the way to...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics